Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: Colonic dysbiosis contributes to the development of colonic inflammation in ulcerative colitis (UC). Fecal microbial transplantation (FMT) is being proposed as a novel treatment for UC because it can eliminate dysbiosis; however, no prospective data exist. We initiated a pilot study to evaluate feasibility and safety of FMT in children with UC. METHODS: Ten children, 7 to 21 years of age, with mild-to-moderate UC (pediatric UC activity index [PUCAI] between 15 and 65) received freshly prepared fecal enemas daily for 5 days. Data on tolerability, adverse events, and disease activity were collected during FMT and weekly for 4 weeks after FMT. Clinical response was defined as decrease in PUCAI by >15, and decrease in PUCAI to <10 was considered clinical remission. RESULTS: No serious adverse events were noted. Mild (cramping, fullness, flatulence, bloating, diarrhea, and blood in stool) to moderate (fever) adverse events were self-limiting. One subject could not retain fecal enemas. Average tolerated enema volume by remaining 9 subjects was 165 mL/day. After FMT, 7 of the 9 (78%) subjects showed clinical response within 1 week, 6 of the 9 (67%) subjects maintained clinical response at 1 month, and 3 of the 9 (33%) subjects achieved clinical remission at 1 week after FMT. Median PUCAI significantly improved after FMT (P = 0.03) compared with the baseline. CONCLUSIONS: Fecal enemas were feasible and tolerated by children with UC. Adverse events were acceptable, self-limiting, and manageable by subjects. FMT indicated efficacy in the treatment of UC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These reports were followed by a number of small studies of FMT in children and adults with UC, CD, and pouchitis with mixed results.64–72”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [68]
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 6×
“A recent study (7) evaluating the role of FMT in treating recurrent C difficile infection reported adverse events, which, similar to our study, were predominantly GI symptoms.”
BackgroundMethodResultInfluentialDysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713 · cited 1×
“The colonic microbiome in patients with UC has decreased richness and diversity (2,3) and is dysfunctional (4) (dysbiosis).”
BackgroundTurner, D., Otley, A. R., Mack, D., Hyams, J., de Bruijne, J., Uusoue, K., Walters, T. D., Zachos, M., Mamula, P., Beaton, D. E., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.029 · Cited by 1,072 · cited 2×
“Therefore, clinical response was defined as a decrease in PUCAI by >15 points after FMT (17).”
BackgroundMethodTreating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003 · cited 2×
“Donor exclusion criteria were guided by our IND, the American Association of Blood Bank Donor History Questionnaire version 1.1, and the recommendations from the American Gastroenterological Association (16).”
BackgroundInfluentialHamilton, M. J., Weingarden, A. R., Sadowsky, M. J., & Khoruts, A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.482 · Cited by 738 · cited 1×
“Multiple studies have used various bowel sterilizing preparations (antibiotics and bowel cleanout) before FMT (19,20) to help donor microbiota establish in the new host.”
BackgroundKhoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 2×
“Recent evidence suggests that FMT, the infusion of fecal preparation from a healthy donor into the GI tract of a patient, is capable of altering the gut microbiome of the new host (6,7).”
BackgroundMethodGophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F., & Veldhuyzen van Zanten, S. J. O. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01004-06 · Cited by 550
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases
Peterson, D. A., Frank, D. N., Pace, N. R., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.001 · Cited by 503 · cited 1×
“The colonic microbiome in patients with UC has decreased richness and diversity (2,3) and is dysfunctional (4) (dysbiosis).”
BackgroundTursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489 · cited 1×
“Probiotics, for example, VSL#3, have shown some usefulness in the treatment of UC (5); however, not all probiotic formulations contain the same species, their efficacy may be strain specific, and understanding of their mechanism of action in the complex gastrointestinal (GI) microbiome is lacking.”
BackgroundTreatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Borody, T. J., Warren, E. F., Leis, S., Surace, R., & Ashman, O. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200307000-00012 · Cited by 388 · cited 3×
“As reported previously (10), because of the chronic process of colonic inflammation, multiple FMT sessions may be needed to see a clinical response in UC.”
BackgroundMethod
Cited by
Items 101–200 of 343
Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
Pavel, F. M., Vesa, C. M., Gheorghe, G., Diaconu, C. C., Stoicescu, M., Munteanu, M. A., Babeş, E. E., Ţiţ, D. M., Toma, M. M., & BUNGAU, S. G. (2021) · Diagnostics · doi:10.3390/diagnostics11061090 · Cited by 72
“They monitored nine children with UC who received FMT via enema, in one session per day, for five consecutive days [141].”
MethodBerg, D., Clemente, J. C., & Colombel, J.-F. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1013031 · Cited by 64
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
Cohen, N. A., & Maharshak, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4535-9 · Cited by 71
Clinical Evidence for the Microbiome in Inflammatory Diseases
Slingerland, A. E., Schwabkey, Z. I., Wiesnoski, D. H., & Jenq, R. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00400 · Cited by 70
“Treatment with a series of five once-daily transplants induced remission that was sustained throughout the month-long trial period in three of nine subjects, and clinical response was observed in another five patients by the conclusion of the trial (76).”
BackgroundKellermayer, R., Nagy-Szakal, D., Harris, A. R., Luna, R. A., Pitashny, M., Schady, D., Mir, S. A. V., Lopez, M. E., Gilger, M. A., Belmont, J., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.19 · Cited by 68
The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease.
Wang, H., Zhou, C., Huang, J., Kuai, X., & Shao, X. (2020) · PubMed Central · Cited by 68
Russell, G. H., Kaplan, J. L., Youngster, I., Baril‐Dore, M., Schindelar, L., Hohmann, E., & Winter, H. S. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000283 · Cited by 64
Allegretti, J. R., Kassam, Z., Osman, M., Budree, S., Fischer, M., & Kelly, C. R. (2017) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2017.05.036 · Cited by 63
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis
Chen, W.-X., Ren, L., & Shi, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15657 · Cited by 64
The microbiota and immune‐mediated diseases: Opportunities for therapeutic intervention
Fitzgibbon, G., & Mills, K. H. G. (2020) · European Journal of Immunology · doi:10.1002/eji.201948322 · Cited by 62
Oral Microbiota Transplant: A Potential New Therapy for Oral Diseases
Nascimento, M. M. (2017) · Journal of the California Dental Association · doi:10.1080/19424396.2017.12222506 · Cited by 61
Wadan, A.-H. S., El‐Aziz, M. K. A., & Ellakwa, D. E. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04155-2 · Cited by 61
“Considering the MGBA, there is growing interest in repurposing these agents for neurodevelopmental conditions like ASD and ADHD, where microbial imbalances and gut dysfunctions are often observed (Kim et al. 2022).”
InfluentialFecal Microbiota Transplantation for multidrug-resistant organism: Efficacy and Response prediction
Seong, H., Lee, S. K., Cheon, J. H., Yong, D., Koh, H., Kang, Y., Jeong, W. Y., Lee, W. J., Sohn, Y., Cho, Y., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.09.003 · Cited by 57
Fecal microbiota transplantation in children: a brief review
Hourigan, S. K., & Oliva‐Hemker, M. M. (2016) · Pediatric Research · doi:10.1038/pr.2016.48 · Cited by 56
“(46) delivered FMT to children and young adults with UC via serial enemas and reported that six of nine patients maintained a clinical response at 1 mo, as manifested by a decrease in Pediatric Ulcerative Colitis Activity Index (PUCAI) score of Table 1.”
Kedia, S., Rampal, R., Paul, J., & Ahuja, V. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1193-1 · Cited by 56
“FMT was well tolerated and no study reported any serious adverse events.”
BackgroundInfluentialCan the gastrointestinal microbiota be modulated by dietary fibre to treat obesity?
Davis, H. C. (2017) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-017-1686-9 · Cited by 54
Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.
Gianotti, R. J., & Moss, A. C. (2017) · Europe PMC (PubMed Central) · Cited by 53
Sood, A., Mahajan, R., Juyal, G., Midha, V., Grewal, C. S., Mehta, V., Singh, A., Joshi, M. C., Narang, V., Kaur, K., et al. (2018) · Intestinal Research · doi:10.5217/ir.2018.00089 · Cited by 53
Effect of Triptolide on Dextran Sodium Sulfate-Induced Ulcerative Colitis and Gut Microbiota in Mice
Wu, H., Rao, Q., Ma, G., Yu, X., Zhang, C.-E., & Ma, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01652 · Cited by 50
Verbeke, K., Boesmans, L., & Boets, E. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114000639 · Cited by 51
Wang, Y., Ren, R., Sun, G., Peng, L., Tian, Y., & Yang, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106661 · Cited by 49
Zhao, H. L., Chen, S. Z., Xu, H. M., Zhou, Y. L., He, J., Huang, H. L., Xu, J., & Nie, Y. Q. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12933 · Cited by 48
Current stage in inflammatory bowel disease: What is next?
Gómez, G. J., Masedo, Á., Yela, C., Martínez-Montiel, M. D. P., & Casís, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11282 · Cited by 47
Allegretti, J. R., Eysenbach, L. M., El‐Nachef, N., Fischer, M., Kelly, C. R., & Kassam, Z. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001247 · Cited by 48
Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity
Meng, X. L., Zhou, H., Shen, H., Lufumpa, E., Li, X., Guo, B., & Li, B. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.006 · Cited by 47
Karolewska‐Bochenek, K., Grzesiowski, P., Banaszkiewicz, A., Gawrońska, A., Kotowska, M., Dziekiewicz, M., Albrecht, P., Radzikowski, A., & Łazowska‐Przeorek, I. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_123 · Cited by 45
Canadian Association of Gastroenterology Position Statement: Fecal Microbiota Transplant Therapy
Moayyedi, P., Marshall, J. K., Yuan, Y., & Hunt, R. H. (2014) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2014/346590 · Cited by 44
Lee, W. J., Lattimer, L., Stephen, S., Borum, M. L., & Doman, D. B. (2015) · PubMed Central · Cited by 44
Sun, D., Li, W., Li, S., Cen, Y., Xu, Q., Li, Y., Sun, Y., Qi, Y., Lin, Y., Yang, T., et al. (2016) · Medicine · doi:10.1097/md.0000000000003765 · Cited by 44
“The primary outcome was clinical remission of UC, defined as Mayo score 2,(9,11,23) or pediatric UC activity index <10.(10,24) Studies without reported clinical endpoints were excluded.”
BackgroundMethodFecal Transplant in Inflammatory Bowel Disease
Browne, A. S., & Kelly, C. R. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.08.005 · Cited by 44
Recipe for IBD: can we use food to control inflammatory bowel disease?
Witkowski, M., Witkowski, M., Gagliani, N., & Huber, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0658-5 · Cited by 44
Zhang, J., Rodríguez, F., Navas, M. J., Costa-Hurtado, M., Almagro, V., Bosch-Camós, L., López, E., Cuadrado‐Matías, R., Accensi, F., Pina-Pedrero, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74651-3 · Cited by 44
Current and future applications of fecal microbiota transplantation for children
Chen, C.-C., & Chiu, C. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.11.004 · Cited by 43
“[40] Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad Jr H, et al.”
BackgroundZhang, T., Cui, B., Li, P., He, Z., Long, C., Wei, L., Peng, Z., Ji, G., & Zhang, F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158227 · Cited by 39
Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome
Fitzgerald, R. S., Sanderson, I. R., & Claesson, M. J. (2021) · Microbial Ecology · doi:10.1007/s00248-021-01697-9 · Cited by 44
Fecal Microbial Transplantation in Early‐Onset Colitis: Caution Advised
Vandenplas, Y., Veereman, G., van der Werff ten Bosch, J., Goossens, A., Pierard, D., Samsom, J. N., & Escher, J. C. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000281 · Cited by 41
“To our knowledge, this is the first report of a successful fecal transplant in a child with early-onset colitis (3).”
BackgroundBretto, E., Caviglia, G. P., Saracco, G. M., Bugianesi, E., & Ribaldone, D. G. (2025) · Biomedicines · doi:10.3390/biomedicines13081807 · Cited by 41
“In the same way, Costello et al. documented a notably superior treatment effect in the study group, consisting of 38 patients with moderate UC who underwent FMT, in contrast to the control group with 35 patients in the placebo arm [179].”
Broecker, F., Kube, M., Klumpp, J., Schuppler, M., Biedermann, L., Hecht, J., Hombach, M., Keller, P. M., Rogler, G., & Moelling, K. (2013) · Digestion · doi:10.1159/000355955 · Cited by 41
Chen, M., Liu, X. L., Zhang, Y. J., Nie, Y. Z., Wu, K., & Yong Quan, S. H. I. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12938 · Cited by 40
Niu, W., Yang, F., Fu, Z., Dong, Y., Zhang, Z., & Ju, J. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105381 · Cited by 40
Sood, A., Singh, A., Mahajan, R., Midha, V., Mehta, V., Gupta, Y. K., Narang, V., & Kaur, K. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14829 · Cited by 39
Management of ulcerative colitis
Fell, J. M. E., Muhammed, R., Spray, C., Crook, K., Russell, R. K., & BSPGHAN IBD working group (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2014-307218 · Cited by 38
The Environment Within: Exploring the Role of the Gut Microbiome in Health and Disease
Konkel, L. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.121-a276 · Cited by 38
“Researchers on the leading edge of microbial therapy are experimenting with fecal transplantation to help restore healthy microbial communities in patients with inflammatory bowel diseases.(27) Others are hopeful that microbiome studies will lead to therapies for a variety of diseases—immunological, metabolic, and neu…”
BackgroundFecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet
Grinspan, A. M., & Kelly, C. R. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.030 · Cited by 38
Singh, M., Chand, H. S., Banerjee, S., Agarwal, H. S., Raizada, V., Roy, S., & Sopori, M. L. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05838-6 · Cited by 37
Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
Wang, A. Y., Popov, J., & Pai, N. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i47.10304 · Cited by 38
Quagliariello, A., CHIERICO, F. D., Reddel, S., Russo, A., Muda, A. O., D’Argenio, P., Angelino, G., Romeo, E. F., Dall’Oglio, L., Angelis, P. D., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8101486 · Cited by 36
Fecal Microbiota Transplantation for Gastrointestinal Diseases
Matsuoka, K., Mizuno, S., Hayashi, A., Hisamatsu, T., Naganuma, M., & Kanai∥, T. (2014) · The Keio Journal of Medicine · doi:10.2302/kjm.2014-0006-re · Cited by 36
The practice of fecal microbiota transplantation in inflammatory bowel disease
Arora, U., Kedia, S., & Ahuja, V. (2023) · Intestinal Research · doi:10.5217/ir.2023.00085 · Cited by 35
“111,137,138 One in 5 patients undergoing FMT experience adverse events, including gastrointestinal symptoms such as diarrhea (10%), and abdominal pain, cramps, or bloating (7%), that are considered transient, mild, and self limiting.”
BackgroundScaldaferri, F., Pecere, S., Petito, V., Zambrano, D., Fiore, L., Lopetuso, L. R., Schiavoni, E., Bruno, G., Gerardi, V., Laterza, L., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.12.040 · Cited by 35
Fecal Microbiota Transplantation and Its Potential Therapeutic Uses in Gastrointestinal Disorders
Heath, R. D., Cockerell, C., Mankoo, R., Ibdah, J. A., & Tahan, V. (2017) · Northern Clinics of Istanbul · doi:10.14744/nci.2017.10692 · Cited by 36
“, 2013 [52] Cohort study Enema 10 33% clinical response at 1 month”
BackgroundThe role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
Haifer, C., Leong, R. W. L., & Paramsothy, S. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.08.009 · Cited by 35
“However, despite the first cohort study of FMT in IBD involving a paediatric cohort [31], data on FMT in the paediatric setting are limited.”
Levast, B., Fontaine, M., Nancey, S., Déchelotte, P., Dore, J. M., & Lehert, P. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000568 · Cited by 35
New targets for the treatment of ulcerative colitis: Gut microbiota and its metabolites
Li, H., Pan, M., Li, Y., Cui, M., & Zhang, M. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.006 · Cited by 32
Cao, Y., Zhang, B., Wu, Y., Wang, Q., Wang, J., & Shen, F. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/5480961 · Cited by 33
“UC patients among six studies (n = 133) [45, 48, 51, 52, 57, 58] used fresh feces with an overall clinical remission rate of 25.”
MethodUmesaki, Y. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.313 · Cited by 34
Zeitz, J., Bissig, M., Barthel, C., Biedermann, L., Scharl, S., Pohl, D., Frei, P., Vavricka, S. R., Fried, M., Rogler, G., et al. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000783 · Cited by 32
Hsu, M., Tun, K. M., Batra, K., Haque, L., Vongsavath, T., & Hong, A. S. (2023) · Microorganisms · doi:10.3390/microorganisms11051272 · Cited by 31
“, 2013 [41] Case series NOS 6 10 7–20 6 male 4 female None 6”
BackgroundInfluentialHow to Manipulate the Microbiota: Fecal Microbiota Transplantation
Fuentes, S., & de Vos, W. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-31248-4_10 · Cited by 31
Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?
Wang, M., Shi, J., Yu, C., Zhang, X., Xu, G., Xu, Z., & Ma, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1298186 · Cited by 30
Park, S., Kang, Y., Koh, H., & Kim, S. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2019.00500 · Cited by 30
“The clinical trials and their results of FMT in pediatric IBD patients are summarized in Table 2.(90-100) FMT has been considered a relatively safe treatment modality with a low rate of adverse events, when there was a thorough investigation of donor fecal material.”
BackgroundInflammatory bowel disease and the gut microbiota
Wu, N., Mah, C., Koentgen, S., Zhang, L., Grimm, M., El-Omar, E. M., & Hold, G. L. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s002966512100197x · Cited by 30
“A paediatric case series subsequently found that seven out of nine patients with mild-to-moderate UC disease activity experienced clinical improvement, and three achieved clinical remission within 1 week after a 5-d course of daily FMT enema((86)).”
Nicholson, M. R., Alexander, E., Ballal, S. A., Davidovics, Z. H., Docktor, M., Dole, M., Gisser, J. M., Goyal, A., Hourigan, S. K., Jensen, M. K., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab202 · Cited by 30
Vendrik, K. E. W., Chernova, V. O., Kuijper, E. J., Terveer, E. M., van Hilten, J. J., & Contarino, M. F. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-071766 · Cited by 29
Pai, N., & Popov, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016698 · Cited by 28
“Protocols and response rates varied across each study, but lower gastrointestinal tract administration yielded clinical response rates in 67%–100% of patients.(13) 14 Two single- centre paediatric case reports have been recently published showing marked clinical improvement in two patients with severe colitis.”
Repeated fecal microbiota transplantation in a child with ulcerative colitis
Shimizu, H., Arai, K., Abe, J., Nakabayashi, K., Yoshioka, T., Hosoi, K., & Kuroda, M. (2016) · Pediatrics International · doi:10.1111/ped.12967 · Cited by 27
Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists
Syal, G., Kashani, A., & Shih, D. Q. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.03.010 · Cited by 26
Fecal microbiota transplantation in childhood: past, present, and future
Gu, X., Chen, Z.-H., & Zhang, S. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-022-00655-w · Cited by 26
Role of fecal microbiota transplantation in inflammatory bowel disease
D'Odorico, I., Bella, S. D., Monticelli, J., Giacobbe, D. R., Boldock, E., & Luzzati, R. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12603 · Cited by 26
“(2013) Non-relative (4) Frozen Kunde et al.(21) (2013) Relative (9), friend (1) Fresh Damman et al.”
BackgroundInfluentialUlcerative colitis: management in adults, children and young people (NICE Clinical Guideline CG166)
Stenke, E., & Hussey, S. (2014) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2013-305512 · Cited by 24
Pai, N., Popov, J., Hill, L., & Hartung, E. E. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030120 · Cited by 24
Fecal Microbial Therapy: Promises and Pitfalls
Merenstein, D. J., El‐Nachef, N., & Lynch, S. V. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000415 · Cited by 24
“Similar results were noted in a study of pediatric and young adult patients with IBD who underwent FMT (32).”
BackgroundResultFecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
Gupta, K., Tappiti, M., Nazir, A. M., Koganti, B., Memon, M. S., Zahid, M. B. A., Kumar, V. S., & Mostafa, J. A. (2022) · Cureus · doi:10.7759/cureus.24754 · Cited by 23
“In addition, many case reports have mentioned the side effects like fever, abdominal pain, diarrhea, exhaustion, flatulence, fatigue, diverticulitis, bacteremia, norovirus gastroenteritis, cytomegalovirus infection, and activation of ulcerative colitis over a short period [17-23].”
BackgroundGreen, J. E., McGuinness, A. J., Berk, M., Castle, D. J., Athan, E., Hair, C., Strandwitz, P., Loughman, A., Nierenberg, A. A., Cryan, J. F., et al. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01235-z · Cited by 23
“safety of FMT The safety of FMT has been established across multiple patient populations [29], including immunocompromised [49] and paediatric populations [50], and over the long term [51].”
BackgroundSinghi, S. C., & Jayashre, M. (2009) · PubMed · Cited by 23
Fecal microbiota transplantation in children: current concepts
Gurram, B., & Sue, P. K. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000787 · Cited by 23
“Several other reports have demonstrated similar efficacy and transient response [55,56].”
ResultMazzawi, T. R. E., Hausken, T., Refsnes, P. F., Hatlebakk, J. G., & Lied, G. A. (2022) · Microorganisms · doi:10.3390/microorganisms10091819 · Cited by 21
Kumagai, H., Yokoyama, K., Imagawa, T., Inoue, S., Tulyeu, J., Tanaka, M., & Yamagata, T. (2016) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2016.19.3.214 · Cited by 21
“Previous reports of successful outcomes associated with FMT for UC involved patients with relatively mild disease [4,11,12].”
ResultSafety of fecal microbiota transplantation in chinese children: A single-center retrospective study
Zhang, X., Wang, Y., Li, X., Hu, H., Liu, H., Li, D., Xiao, Y., & Zhang, T. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i161.1121 · Cited by 21
Manipulation of Microbiome, a Promising Therapy for Inflammatory Bowel Diseases
Zhang, D. J. H. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000234 · Cited by 20
“, which were tolerable and self-limiting [145].”
Lam, W. C., Zhao, C., Ma, W. J., & Yao, L. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1287493 · Cited by 20
Relapsing and Refractory Ulcerative Colitis in Children
Turner, D. (2014) · Digestive Diseases · doi:10.1159/000358148 · Cited by 19
A clinical primer of the role of gut microbiome in health and disease
Yang, A. L., & Kashyap, P. (2015) · Tropical Gastroenterology · doi:10.7869/tg.238 · Cited by 19
“in 7 out of 9 children with UC within 1 week following fecal transplantation.(42) However, there are concerns about the”
BackgroundKarolewska‐Bochenek, K., Łazowska‐Przeorek, I., Grzesiowski, P., Dziekiewicz, M., Dembiński, Ł., Albrecht, P., Radzikowski, A., & Banaszkiewicz, A. (2020) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/118189 · Cited by 19
Piazzesi, A., & Putignani, L. (2022) · Parasite Immunology · doi:10.1111/pim.12949 · Cited by 20
Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
Zhang, X., Ishikawa, D., Ohkusa, T., Fukuda, S., & Nagahara, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1068567 · Cited by 19
“Although patients can perform FMT with self-enema at home, possible related adverse events such as rectal abscess (18) and left-sided abdominal fullness (50) have been reported.”
BackgroundDang, X., Wang, Q., Zhao, Y., Sun, L., & Yang, W. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01548-w · Cited by 19
Faecal microbiota transplantation in children : A systematic review
Lauwers, E., Sabino, J., Hoffman, I. E. A., & van Hoeve, K. (2024) · Acta Paediatrica · doi:10.1111/apa.17167 · Cited by 18
Developing human gut microbiota as a class of therapeutics
Khoruts, A. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.231 · Cited by 18
From germ theory to germ therapy
Chen, C., Chen, Y., Liou, J., & Wu, M. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12011 · Cited by 18
Wang, J., Liang, Q., Dou, H., & Ou, Y. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15996 · Cited by 17
Boicean, A., Bratu, D. G., Bacila, C. I., Tanasescu, C. A. H., Fleacă, R. S., Mohor, C. I., Comaniciu, A., Băluță, T., Roman, M. D., Chicea, R., et al. (2023) · Pathogens · doi:10.3390/pathogens12060766 · Cited by 17
Human microbiome: From the bathroom to the bedside
Malnick, S. D. H., & Melzer, E. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i3.79 · Cited by 17
Huang, T., Xu, J., Wang, M., Pu, K., Li, L., Zhang, H., Liang, Y., Sun, W., & Wang, Y. (2022) · Medicine · doi:10.1097/md.0000000000029790 · Cited by 15
The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art
Safarpour, A. R., Askari, H., Shojaei‐Zarghani, S., Raeis-Abdollahi, E., Jahromi, H. K., Raise‐Abdullahi, P., Daliri, K., Tajbakhsh, A., & Rahmati, L. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220914093331 · Cited by 15
Chanyi, R. M., Craven, L. J., Harvey, B., Reid, G., Silverman, M., & Burton, J. P. (2017) · SAGE Open Medicine · doi:10.1177/2050312117708712 · Cited by 15
Trasplante de microbiota fecal: primer caso reportado en Chile y revisión de la literatura
Espinoza, R., Quera, R., Meyer, L., & Rivera, D. (2014) · Revista chilena de infectología · doi:10.4067/s0716-10182014000400016 · Cited by 15
Kump, P. K., & Högenauer, C. (2016) · Digestive Diseases · doi:10.1159/000447379 · Cited by 14
Piazzesi, A., & Putignani, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.958346 · Cited by 14
Challenges and opportunities for faecal microbiota transplantation therapy
Rogers, G. B., & Bruce, K. D. (2013) · Epidemiology and Infection · doi:10.1017/s0950268813001362 · Cited by 14
“treatment of children and young adults with ulcerative colitis [62].”
Background
Metadata
- Authors
- Kunde, S., Pham, A., Bonczyk, S., Crumb, T., Duba, M., Conrad, H., Cloney, D., & Kugathasan, S.
- Affiliations
- Spectrum Health (US)
- Michigan State University (US)
- Emory University (US)
- Corresponding author
- Kunde, Sachin
- Pham, Angela
- Crumb, Teri
- Duba, Meg
- Conrad, Harold
- Cloney, Deborah
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2013-06
- Volume
- 56
- Issue
- 6
- Pages
- 597-601
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2121245825
- Cited by
- 314
- References
- 26
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 8 · 2023: 14 · 2022: 14 · 2021: 17 · 2020: 26 · 2019: 26 · 2018: 23 · 2017: 40 · 2016: 34 · 2015: 38 · 2014: 42 · 2013: 16
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Surgery › Anorectal Disease Treatments and Outcomes
- Keywords
- fecal microbiota transplantation, ulcerative colitis, pediatric inflammatory bowel disease, colonic dysbiosis, clinical remission, safety and tolerability, adverse events, disease activity
- MeSH terms
- Administration, Rectal, Adolescent, Adult, Biological Therapy, Child, Colitis, Ulcerative, Family, Feasibility Studies, Feces, Female, Follow-Up Studies, Hospitals, Pediatric, Humans, Male, Michigan, Outpatient Clinics, Hospital, Pilot Projects, Remission Induction, Severity of Illness Index, Therapies, Investigational, Donor Selection, Young Adult, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.